HomeCTOR • NASDAQ
add
Citius Oncology Inc
Previous close
$1.05
Day range
$0.95 - $1.02
Year range
$0.55 - $6.19
Market cap
84.80M USD
Avg Volume
711.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.71M | -29.35% |
Net income | -5.00M | 26.66% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -5.58% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.92M | 3,504,282.14% |
Total assets | 100.94M | 19.64% |
Total liabilities | 56.08M | 46.69% |
Total equity | 44.87M | — |
Shares outstanding | 84.80M | — |
Price to book | 1.94 | — |
Return on assets | -12.23% | — |
Return on capital | -27.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.00M | 26.66% |
Cash from operations | -5.49M | -4,446.59% |
Cash from investing | -5.75M | -15.00% |
Cash from financing | 15.17M | 211.19% |
Net change in cash | 3.92M | 3,504,182.14% |
Free cash flow | -15.24M | -113.04% |
About
Founded
2021
Headquarters
Website
